NDAORALTABLET, ORALLY DISINTEGRATING
Approved
Nov 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PROPULSID QUICKSOLV is an orally disintegrating tablet formulation of cisapride monohydrate, a prokinetic agent approved by the FDA in 1997. Cisapride enhances gastric motility and accelerates gastric emptying, making it suitable for patients with gastrointestinal dysmotility disorders. The QuickSolv formulation provides rapid dissolution for improved patient convenience and absorption.
LOE Approaching
With LOE approaching and moderate competitive pressure (30/100), the brand team is likely in defensive/transition mode with reduced headcount and focus on maximizing residual value.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PROPULSID QUICKSOLV offers limited long-term career growth potential given its approaching loss of exclusivity and zero linked job openings. This role is best suited for professionals seeking experience in mature product management or preparing for product lifecycle transitions.
Brand ManagerField Sales Representative
Worked on PROPULSID QUICKSOLV at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.